ARALEZ PHARMACEUTICALS INC. (NASDAQ:ARLZ) Files An 8-K Financial Statements and Exhibits

ME Staff 8-k
-
0

ARALEZ PHARMACEUTICALS INC. (NASDAQ:ARLZ) Files An 8-K Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits

(a)Pro-Forma Financial Information

Unaudited pro forma condensed combined statement of operations for the year ended December31, 2016 and the notes related thereto, which reflect the Applicable Transactions, are filed as Exhibit99.1 to this report and incorporated herein by reference.

EXHIBIT NO.

DESCRIPTION

99.1

Unaudited pro forma condensed combined statement of operations for the year ended December31, 2016.

99.2

Consent of PricewaterhouseCoopers LLP


Aralez Pharmaceuticals Inc. Exhibit
EX-99.1 2 a17-26264_2ex99d1.htm EX-99.1 Exhibit 99.1   UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION   The following unaudited pro forma condensed combined financial information has been prepared to illustrate the effects of (i) the Merger Transaction which was completed on February 5,…
To view the full exhibit click here

About ARALEZ PHARMACEUTICALS INC. (NASDAQ:ARLZ)

Aralez Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).